September 24, 2025
Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen
CAMBRIDGE, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug…
Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug…
CARLSBAD, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) — Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), a leading formulator, manufacturer, and…
SAN DIEGO, Sept. 23, 2025 (GLOBE NEWSWIRE) — Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on…
OSE Immunotherapeutics acknowledges the decision of the Nantes Commercial Court NANTES, France – September 23, 2025, 10:30 p.m. CET –…
Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology…
– Cyclerion Relaunches, Advancing a Phase 2–Ready Program for Millions Living with Treatment-Resistant Depression Through MIT License Agreement – – Webcast to be…
TestoPrime launch a Effective and Best Testosterone Booster Supplement For Men 40 or 50, this is most popular and natural…
Aggregated presentation by day and by marketStatement of transactions in own shares from September 15th to September 19th 2025 Name of…
PALO ALTO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) — Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR, SMNRW) ,…
BioLegacy’s New Vancouver Hub Drives Innovation in Opioid Crisis Solutions with Unmatched Manufacturing and Research CapabilitiesVANCOUVER, British Columbia, Sept. 23,…